Tenderwize
Retour à la recherche

Open-house rebate agreements for colchicine

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Aug 03, 2027 · 339 days left·Open·Supplies·Framework
Inscrivez-vous pour sauvegarderOpen documents
Titre original de l'avis

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Colchicin, ATC M04AC01

56/100

Score d'opportunité

Needs reviewMedium complexity
SuppliesFrameworkOpen
Pourquoi ce score ?

Opportunité

56 / 100

Complexité

48 / 100

Facteurs de risque

Submitting the contract documents in the wrong DTVP area is explicitly prohibited; they must be sent via the communicat...

To obtain the next monthly start date, complete documents must be received by the 3rd of the month; for paper filings...

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Aperçu

Moderate opportunity

Faits clés

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Sep 2027
  • Non-exclusive rebate agreements for pharmaceutical products containing colchicine (ATC M04AC01).
  • Open-house model with identical, non-individually negotiable contract terms for all eligible pharmaceutical companies.
Afficher le résumé complet

Open-house supply arrangement for pharmaceutical products: AOK Bayern seeks non-exclusive rebate agreements for colchicine (ATC M04AC01) with all interested pharmaceutical companies that meet the stated suitability requirement. This is explicitly described as an open-house model, not a competitive open procedure, with no selection among bidders and no negotiated contract terms. The contract period runs from 2025-10-01 to 2027-09-30, and applications can be submitted until 2027-08-03 12:00 local time; for monthly start dates, complete documents must arrive by the 3rd of the month, with paper originals by the 10th if scanned in advance.

Risques

Submitting the contract documents in the wrong DTVP area is explicitly prohibited; they must be sent via the communicat...

To obtain the next monthly start date, complete documents must be received by the 3rd of the month; for paper filings...

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Eligibility

  • Only pharmaceutical companies are eligible as potential contract partners.

Administrative

  • A signed declaration of reliability (Eigenerklärung zur Zuverlässigkeit) must be submitted.
  • The contract must be submitted completed and signed; signatory authority must be evidenced by the commercial register extract or a power of attorney.

Acheteur

Localisation

München, DEU

Site web

www.aok.de

Profil acheteur

Ouvrir le profil

Identifiant

DE811695320

Activité

Health

Lots (1)

LOT-0001

Open-house rebate agreements for colchicine

Supply of pharmaceutical products under an open-house rebate agreement for the active substance colchicine (ATC M04AC01). The lot is for non-exclusive, identical contract terms for interested pharmaceutical companies. Place of performance is Germany, Bavaria (DE212).

SuppliesFrameworkEU fundedElectronic submission

Localisation

DE212, Germany

Durée

Sep 2025 - Sep 2027

Catégorie

Pharmaceutical products

Date limite

Deadline Aug 03, 2027

Détails de la procédure

Date de publication
13 Aug 2025
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
532530-2025

Documents (2)

Document de consultation 1Portail de soumission 1

Appels d'offres similaires

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta

Aug 30